Factors Related to Silent Myocardial Damage in Hemodialysis Patients

REFERENCES

• Santoro A, Mancini E. Cardiac effects of chronic inflammation in dialysis patients. Nephrol Dial Transplant. 2002;17:10–15.
   PubMed Web of Science ®Google Scholar
• Yao Q, Pecoits-Filho R, Lindholm B, Stenvinkel P. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Scand J Urol Nephrol. 2004;38:405–416.
   PubMed Web of Science ®Google Scholar
• Apple FS, Sharkey SW, Hoeft P, Skeate R, Voss E, Dahlmeier BA, Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: A one-year outcomes analysis. Am J Kidney Dis. 1997;29:399–403.
   PubMed Web of Science ®Google Scholar
• Khan IA, Wattanasuwan N, Mehta NJ, Tun A, Singh N, Singh HK, Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis: A two-year outcome analysis. J Am Coll Cardiol. 2001;38:991–998.
   PubMedGoogle Scholar
• Wayand D, Baum H, Schätzle G, Schärf J, Neumeier D. Cardiac troponin T and I in end-stage renal failure. Clin Chem. 2000;46:1345–1350.
   PubMed Web of Science ®Google Scholar
• Schulz O, Sigusch HH. Impact of an exercise-induced increase in cardiac troponin I in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2002;90:547–550.
   PubMedGoogle Scholar
• Roberts MA, Fernando D, Macmillan N, Proimos G, Bach LA, Power DA, Single and serial measurements of cardiac troponin I in asymptomatic patients on chronic hemodialysis. Clin Nephrol. 2004;61:40–46.
   PubMed Web of Science ®Google Scholar
• Beciani M, Tedesco A, Violante A, Cipriani S, Azzarito M, Sturniolo A, Cardiac troponin I (2nd generation assay) in chronic hemodialysis patients: Prevalence and prognostic value. Nephrol Dial Transplant. 2003;18:942–946.
   PubMed Web of Science ®Google Scholar
• Stoffel MP, Pollok M, Baldamus CA. Troponin I is a better prognostic parameter of cardiovascular events in asymptomatic patients on hemodialysis than troponin T. Nephrol Dial Transplant. 2000;15:1259–1260.
   PubMedGoogle Scholar
• Troyanov S, Ly QH, Schampaert E, Ammann H, Lalumière G, Madore F, Diagnostic specificity and prognostic value of cardiac troponins in asymptomatic chronic haemodialysis patients: A three year prospective study. Heart. 2005;91:1227–1228.
   PubMedGoogle Scholar
• Iliou MC, Fumeron C, Benoit MO, Tuppin P, Courvoisier CL, Calonge VM, Chronic Haemodialysis and New Cardiac Markers Evaluation (CHANCE) Study. Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients. Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study. Nephrol Dial Transplant. 2001;16:1452–1458.
   PubMed Web of Science ®Google Scholar
• Konno T, Shimizu M, Ino H, Fujino N, Hayashi K, Uchiyama K, Differences in diagnostic value of four electrocardiographic voltage criteria for hypertrophic cardiomyopathy in a genotyped population. Am J Cardiol. 2005;96:1308–1312.
   PubMedGoogle Scholar
• Knebel F, Schimke I, Eddicks S, Walde T, Ziebig R, Schattke S, Does contrast echocardiography induce increases in markers of myocardial necrosis, inflammation and oxidative stress suggesting myocardial injury?. Cardiovasc Ultrasound. 2005;17:3–21.
   Google Scholar
• Cusack MR, Marber MS, Lambiase PD, Bucknall CA, Redwood SR. Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Coll Cardiol. 2002;39:1917–1923.
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002;53:31–47.
   PubMed Web of Science ®Google Scholar
• Wang M, Tsai BM, Crisostomo PR, Meldrum DR. Tumor necrosis factor receptor signaling resistance in the female myocardium during ischemia. Circulation. 2006;114:I282–1289.
   Google Scholar
• Kubota T, Miyagishima M, Frye CS, Alber SM, Bounoutas GS, Kadokami T, Overexpression of tumor necrosis factor-alpha activates both anti- and pro-apoptotic pathways in the myocardium. J Mol Cell Cardiol. 2001;33:1331–1344.
   PubMedGoogle Scholar
• Antonicelli R, Olivieri F, Cavallone L, Spazzafumo L, Bonafè M, Marchegiani F, Tumor necrosis factor-alpha gene-308G. A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers. Coron Artery Dis. 2005;16:489–493.
   PubMed Web of Science ®Google Scholar
• Löwbeer C, Stenvinkel P, Pecoits-Filho R, Heimbürger O, Lindholm B, Gustafsson SA, Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J. Intern Med. 2003;253:153–160.
   PubMedGoogle Scholar
• Löwbeer C, Ottosson-Seeberger A, Gustafsson SA, Norrman R, Hulting J, Gutierrez A. Increased cardiac troponin T and endothelin-1 concentrations in dialysis patients may indicate heart disease. Nephrol Dial Transplant. 1999;14:1948–1955.
   PubMedGoogle Scholar
• Tun A, Khan IA, Win MT, Hussain A, la TA H, Wattanasuwan N, Specificity of cardiac troponin I and creatine kinase-MB isoenzyme in asymptomatic long-term hemodialysis patients and effect of hemodialysis on these cardiac markers. Cardiology. 1998;90:280–285.
   PubMed Web of Science ®Google Scholar
• Solaro RJ. Troponin I, stunning, hypertrophy, and failure of the heart. Circ Res. 1999;84:122–124.
   PubMedGoogle Scholar
• Martin GS, Becker BN, Schulman G. Cardiac troponin-I accurately predicts myocardial injury in renal failure. Nephrol Dial Transplant. 1998;13:1709–1712.
   PubMed Web of Science ®Google Scholar
• Missov E, Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation. 1997;96:2953–2958.
   PubMed Web of Science ®Google Scholar
• Mashimo Y, Suzuki Y, Hatori K, Tabara Y, Miki T, Tokunaga K, Association of TNFRSF4 gene polymorphisms with essential hypertension. J Hypertens. 2008;26:902–913.
   PubMedGoogle Scholar
• Bacaner M, Brietenbucher J, LaBree J. Prevention of ventricular fibrillation, acute myocardial infarction (myocardial necrosis), heart failure, and mortality by bretylium: Is ischemic heart disease primarily adrenergic cardiovascular disease?. Am J Ther. 2004;11:366–411.
   PubMedGoogle Scholar
• Naya M, Tsukamoto T, Morita K, Katoh C, Furumoto T, Fujii S, Plasma interleukin-6 and tumor necrosis factor-alpha can predict coronary endothelial dysfunction in hypertensive patients. Hypertens Res. 2007;30:541–548.
   PubMed Web of Science ®Google Scholar
• Lip GY, Edmunds E, Nuttall SL, Landray MJ, Blann AD, Beevers DG. Oxidative stress in malignant and non-malignant phase hypertension. J Hum Hypertens. 2002;16:333–336.
   PubMed Web of Science ®Google Scholar
• Ritz E. Atherosclerosis in dialyzed patients. Blood Purif. 2004;22:28–37.
   PubMedGoogle Scholar
• Li S, Collins AJ. Association of hematocrit value with cardiovascular morbidity and mortality in incident hemodialysis patients. Kidney Int. 2004;65:626–633.
   PubMed Web of Science ®Google Scholar
• Duke M, Abelmann WH. The hemodynamic response to chronic anemia. Circulation. 1969;39:503–515.
   PubMed Web of Science ®Google Scholar
• Gunnell J, Yeun JY, Depner TA, Kaysen GA. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 1999;33:63–72.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001;38:1251–1263.
   PubMed Web of Science ®Google Scholar
• Levin A. The role of anaemia in the genesis of cardiac abnormalities in patients with chronic kidney disease. Nephrol Dial Transplant. 2002;17:207–210.
   PubMedGoogle Scholar
• Kalantar-Zadeh K, Supasyndh O, Lehn RS, McAllister CJ, Kopple JD. Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20. J Ren Nutr. 2003;13:15–25.
   PubMedGoogle Scholar
• Shinaberger CS, Kilpatrick RD, Regidor DL, McAllister CJ, Greenland S, Kopple JD, Longitudinal associations between dietary protein intake and survival in hemodialysis patients. Am J Kidney Dis. 2006;48:37–49.
   PubMed Web of Science ®Google Scholar
• Kumagai H, Sakurai M, Takita T, Maruyama Y, Uno S, Ikegaya N, Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients. Am J Kidney Dis. 2006;48:797–805.
   PubMedGoogle Scholar
• Kalantar-Zadeh K. Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: What is next?. Semin Dial. 2005;18:365–369.
   PubMed Web of Science ®Google Scholar
• Caglar M, Mahmoudian B, Aytemir K, Kahraman S, Arici M, Kabakci G, Value of 99mTc-methoxyisobutylisonitrile (99mTc-MIBI) gated SPECT for the detection of silent myocardial ischemia in hemodialysis patients: Clinical variables associated with abnormal test results. Nucl Med Commun. 2006;27:61–69.
   PubMedGoogle Scholar
• Katerinis I, Nguyen Q, Magnin JL, Descombes E. Cardiac findings in asymptomatic chronic hemodialysis patients with persistently elevated cardiac troponin I levels. Ren Fail. 2008;30:357–362.
   PubMed Web of Science ®Google Scholar